Aim of the laboratory is to develop translational molecular medicine studies for novel targeted therapies 

 

 

 

 

  • Studies on molecular pathology mechanisms, genes, antigens and proteins directly involved in tumour, infectious and inflammatory diseases

  • Development of therapeutic molecules and innovative strategies for drug delivery protocols by electric fields in models of human pathologies

  • Administration of DNA vaccines, immunomodulatory molecules and systemic delivery of recombinant proteins in pre-clinical protocols

  • Identification of biomarkers related to tumour, infectious and inflammatory diseases

  • Validation of devices and new materials to transfer in the clinical practice

 

 

Emanuela Signori - MSc, PhD

 eacr new

 


 

 

Felix qui potuit rerum cognoscere causas

Virgilio - Georgiche (II, v. 490)